BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34448021)

  • 41. Prefrontal executive function associated coupling relates to Huntington's disease stage.
    Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
    Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiparametric characterization of white matter alterations in early stage Huntington disease.
    Adanyeguh IM; Branzoli F; Delorme C; Méneret A; Monin ML; Luton MP; Durr A; Sabidussi E; Mochel F
    Sci Rep; 2021 Jun; 11(1):13101. PubMed ID: 34162958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Motor network structure and function are associated with motor performance in Huntington's disease.
    Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
    J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Huntington disease: pathogenesis and treatment.
    Dayalu P; Albin RL
    Neurol Clin; 2015 Feb; 33(1):101-14. PubMed ID: 25432725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading.
    Yefimova MG; Béré E; Cantereau-Becq A; Meunier-Balandre AC; Merceron B; Burel A; Merienne K; Ravel C; Becq F; Bourmeyster N
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limbic system abnormalities associated with Ammon's horn sclerosis do not alter seizure outcome after amygdalohippocampectomy.
    Urbach H; Siebenhaar G; Koenig R; von Oertzen J; Scorzin J; Kurthen M; Schild HH
    Epilepsia; 2005 Apr; 46(4):549-55. PubMed ID: 15816949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.
    Unschuld PG; Joel SE; Pekar JJ; Reading SA; Oishi K; McEntee J; Shanahan M; Bakker A; Margolis RL; Bassett SS; Rosenblatt A; Mori S; van Zijl PC; Ross CA; Redgrave GW
    Psychiatry Res; 2012; 203(2-3):166-74. PubMed ID: 22974690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
    J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anatomy of the Limbic White Matter Tracts as Revealed by Fiber Dissection and Tractography.
    Pascalau R; Popa Stănilă R; Sfrângeu S; Szabo B
    World Neurosurg; 2018 May; 113():e672-e689. PubMed ID: 29501514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease.
    Mühlau M; Weindl A; Wohlschläger AM; Gaser C; Städtler M; Valet M; Zimmer C; Kassubek J; Peinemann A
    J Neural Transm (Vienna); 2007 Mar; 114(3):367-72. PubMed ID: 17024326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural Magnetic Resonance Imaging in Huntington's Disease.
    Wilson H; Dervenoulas G; Politis M
    Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.
    Park M; Moon Y; Han SH; Kim HK; Moon WJ
    Eur Radiol; 2019 Sep; 29(9):4914-4921. PubMed ID: 30488109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fornix Under Water? Ventricular Enlargement Biases Forniceal Diffusion Magnetic Resonance Imaging Indices in Anorexia Nervosa.
    Kaufmann LK; Baur V; Hänggi J; Jäncke L; Piccirelli M; Kollias S; Schnyder U; Pasternak O; Martin-Soelch C; Milos G
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jul; 2(5):430-437. PubMed ID: 29560927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.